96 related articles for article (PubMed ID: 11179828)
1. Antitumor activity of tributyrin in murine melanoma model.
Giermasz A; Nowis D; Jalili A; Basak G; Marczak M; Makowski M; Czajka A; Młynarczuk I; Hoser G; Stok osa T; Lewandowski S; Jakóbisiak M
Cancer Lett; 2001 Mar; 164(2):143-8. PubMed ID: 11179828
[TBL] [Abstract][Full Text] [Related]
2. Novel anticancer prodrugs of butyric acid. 2.
Nudelman A; Ruse M; Aviram A; Rabizadeh E; Shaklai M; Zimrah Y; Rephaeli A
J Med Chem; 1992 Feb; 35(4):687-94. PubMed ID: 1542095
[TBL] [Abstract][Full Text] [Related]
3. Potentiating antitumor effects of a combination therapy with lovastatin and butyrate in the Lewis lung carcinoma model in mice.
Giermasz A; Makowski M; Kozłowska E; Nowis D; Maj M; Jalili A; Feleszko W; Wójcik C; Dabrowska A; Jakóbisiak M; Gołab J
Int J Cancer; 2002 Feb; 97(6):746-50. PubMed ID: 11857349
[TBL] [Abstract][Full Text] [Related]
4. Potentiated antitumor effects of butyrate and actinomycin D in melanoma model in mice.
Giermasz A; Makowski M; Nowis D; Jalili A; Maj M; Dabrowska A; Czajka A; Jakobisiak M; Golab J
Oncol Rep; 2002; 9(1):199-203. PubMed ID: 11748483
[TBL] [Abstract][Full Text] [Related]
5. Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy.
Chen ZX; Breitman TR
Cancer Res; 1994 Jul; 54(13):3494-9. PubMed ID: 8012972
[TBL] [Abstract][Full Text] [Related]
6. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
Scappaticci FA; Smith R; Pathak A; Schloss D; Lum B; Cao Y; Johnson F; Engleman EG; Nolan GP
Mol Ther; 2001 Feb; 3(2):186-96. PubMed ID: 11237675
[TBL] [Abstract][Full Text] [Related]
7. Hypoestoxide, a natural nonmutagenic diterpenoid with antiangiogenic and antitumor activity: possible mechanisms of action.
Ojo-Amaize EA; Nchekwube EJ; Cottam HB; Bai R; Verdier-Pinard P; Kakkanaiah VN; Varner JA; Leoni L; Okogun JI; Adesomoju AA; Oyemade OA; Hamel E
Cancer Res; 2002 Jul; 62(14):4007-14. PubMed ID: 12124334
[TBL] [Abstract][Full Text] [Related]
8. Tributyrin induces differentiation, growth arrest and apoptosis in androgen-sensitive and androgen-resistant human prostate cancer cell lines.
Maier S; Reich E; Martin R; Bachem M; Altug V; Hautmann RE; Gschwend JE
Int J Cancer; 2000 Oct; 88(2):245-51. PubMed ID: 11004676
[TBL] [Abstract][Full Text] [Related]
9. The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway.
de Conti A; Tryndyak V; Koturbash I; Heidor R; Kuroiwa-Trzmielina J; Ong TP; Beland FA; Moreno FS; Pogribny IP
Carcinogenesis; 2013 Aug; 34(8):1900-6. PubMed ID: 23568954
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug.
Kraus-Berthier L; Guilbaud N; Léonce S; Parker T; Genissel P; Guillonneau C; Goldstein S; Atassi G; Pierré A
Cancer Chemother Pharmacol; 2002 Aug; 50(2):95-103. PubMed ID: 12172972
[TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of tributyrin emulsion as a potent anti-cancer agent against melanoma.
Kang SN; Lee E; Lee MK; Lim SJ
Drug Deliv; 2011 Feb; 18(2):143-9. PubMed ID: 20946006
[TBL] [Abstract][Full Text] [Related]
12. Suramin augments the antitumor and antimetastatic activity of pentoxifylline in B16F10 melanoma.
Dua P; Ingle A; Gude RP
Int J Cancer; 2007 Oct; 121(7):1600-8. PubMed ID: 17582610
[TBL] [Abstract][Full Text] [Related]
13. A New Synthetic Spiroketal: Studies on Antitumor Activity on Murine Melanoma Model In Vivo and Mechanism of Action In Vitro.
Fuggetta MP; Spanu P; Ulgheri F; Deligia F; Carta P; Mannu A; Trotta V; De Cicco R; Barra A; Zona E; Morelli F
Anticancer Agents Med Chem; 2019; 19(4):567-578. PubMed ID: 30706794
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic and antitumor activity of IDN 5390, a new taxane derivative.
Taraboletti G; Micheletti G; Rieppi M; Poli M; Turatto M; Rossi C; Borsotti P; Roccabianca P; Scanziani E; Nicoletti MI; Bombardelli E; Morazzoni P; Riva A; Giavazzi R
Clin Cancer Res; 2002 Apr; 8(4):1182-8. PubMed ID: 11948131
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
[TBL] [Abstract][Full Text] [Related]
16. Augmented antitumour effects of combination therapy with TNP-470 and chemoimmunotherapy in mice.
Dabrowska-Iwanicka A; Olszewska D; Jalili A; Makowski M; Grzela T; Marczak M; Hoser G; Giermasz A; Golab J; Jakóbisiak M
J Cancer Res Clin Oncol; 2002 Aug; 128(8):433-42. PubMed ID: 12200600
[TBL] [Abstract][Full Text] [Related]
17. Tributyrin, a stable and rapidly absorbed prodrug of butyric acid, enhances antiproliferative effects of dihydroxycholecalciferol in human colon cancer cells.
Gaschott T; Steinhilber D; Milovic V; Stein J
J Nutr; 2001 Jun; 131(6):1839-43. PubMed ID: 11385076
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of cholesteryl butyrate solid lipid nanospheres as a butyric acid pro-drug on melanoma cells: evaluation of antiproliferative activity and apoptosis induction.
Salomone B; Ponti R; Gasco MR; Ugazio E; Quaglino P; Osella-Abate S; Bernengo MG
Clin Exp Metastasis; 2000; 18(8):663-73. PubMed ID: 11827070
[TBL] [Abstract][Full Text] [Related]
19. Dual function of tributyrin emulsion: solubilization and enhancement of anticancer effect of celecoxib.
Kang SN; Hong SS; Lee MK; Lim SJ
Int J Pharm; 2012 May; 428(1-2):76-81. PubMed ID: 22405988
[TBL] [Abstract][Full Text] [Related]
20. Derivatives of butyric acid as potential anti-neoplastic agents.
Rephaeli A; Rabizadeh E; Aviram A; Shaklai M; Ruse M; Nudelman A
Int J Cancer; 1991 Aug; 49(1):66-72. PubMed ID: 1874573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]